Cargando…

Interactions Between ABCB1 Genotype and Preoperative Statin Use Impact Clinical Outcomes Among Breast Cancer Patients

Multiple clinical trials investigate statins' effects in breast cancer. The ABCB1 genotype appears to influence statin response and toxicity in the cardiovascular setting. This exploratory study aimed to investigate the interplay between preoperative statin use, ABCB1 genotype, and tumor-specif...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tryggvadottir, Helga, Huzell, Louise, Gustbée, Emma, Simonsson, Maria, Markkula, Andrea, Jirström, Karin, Rose, Carsten, Ingvar, Christian, Borgquist, Signe, Jernström, Helena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6194198/ https://www.ncbi.nlm.nih.gov/pubmed/30370250 http://dx.doi.org/10.3389/fonc.2018.00428

Ejemplares similares

Tumor-specific expression of HMG-CoA reductase in a population-based cohort of breast cancer patients
por: Gustbée, Emma, et al.
Publicado: (2015)

Coffee Is Associated With Lower Breast Tumor Insulin-Like Growth Factor Receptor 1 Levels in Normal-Weight Patients and Improved Prognosis Following Tamoxifen or Radiotherapy Treatment
por: Björner, Sofie, et al.
Publicado: (2018)

Excessive milk production during breast-feeding prior to breast cancer diagnosis is associated with increased risk for early events
por: Gustbée, Emma, et al.
Publicado: (2013)

Body Mass Index Influences the Prognostic Impact of Combined Nuclear Insulin Receptor and Estrogen Receptor Expression in Primary Breast Cancer
por: Björner, Sofie, et al.
Publicado: (2017)

Combined and individual tumor-specific expression of insulin-like growth factor-I receptor, insulin receptor and phospho-insulin-like growth factor-I receptor/insulin receptor in primary breast cancer: Implications for prognosis in different treatment groups
por: Björner, Sofie, et al.
Publicado: (2016)

Increasing preoperative body size in breast cancer patients between 2002 and 2016: implications for prognosis
por: Wisse, Agatha, et al.
Publicado: (2018)

Re-evaluation of HER2 status in 606 breast cancers—gene protein assay on tissue microarrays versus routine pathological assessment
por: Sandén, Emma, et al.
Publicado: (2020)

IL6 genotype, tumour ER-status, and treatment predicted disease-free survival in a prospective breast cancer cohort
por: Markkula, Andrea, et al.
Publicado: (2014)

Patient Characteristics Influence Activated Signal Transducer and Activator of Transcription 3 (STAT3) Levels in Primary Breast Cancer—Impact on Prognosis
por: Nilsson, Linn, et al.
Publicado: (2020)

Impact of COX2 genotype, ER status and body constitution on risk of early events in different treatment groups of breast cancer patients
por: Markkula, Andrea, et al.
Publicado: (2014)

Caveolin-1 genotypes as predictor for locoregional recurrence and contralateral disease in breast cancer
por: Godina, Christopher, et al.
Publicado: (2023)

CYP1A2 – a novel genetic marker for early aromatase inhibitor response in the treatment of breast cancer patients
por: Simonsson, Maria, et al.
Publicado: (2016)

Impacts of smoking on endocrine treatment response in a prospective breast cancer cohort
por: Persson, Mia, et al.
Publicado: (2016)

Prognostic impact of tumor-specific insulin-like growth factor binding protein 7 (IGFBP7) levels in breast cancer: a prospective cohort study
por: Godina, Christopher, et al.
Publicado: (2021)

Pre- and postoperative alcohol consumption in breast cancer patients: impact on early events
por: Simonsson, Maria, et al.
Publicado: (2014)

Prognostic Impact of Menopausal Hormone Therapy in Breast Cancer Differs According to Tumor Characteristics and Treatment
por: Godina, Christopher, et al.
Publicado: (2020)

CYP27A1 expression is associated with risk of late lethal estrogen receptor-positive breast cancer in postmenopausal patients
por: Kimbung, Siker, et al.
Publicado: (2020)

The Prognostic Impact of Intratumoral Aryl Hydrocarbon Receptor in Primary Breast Cancer Depends on the Type of Endocrine Therapy: A Population-Based Cohort Study
por: Tryggvadottir, Helga, et al.
Publicado: (2021)

Interplay between Caveolin-1 and body and tumor size affects clinical outcomes in breast cancer
por: Godina, Christopher, et al.
Publicado: (2022)

Statin use and patterns of breast cancer recurrence in the Malmö Diet and Cancer Study
por: Inasu, Maria, et al.
Publicado: (2022)

Pre- and Postoperative Circulating IGF-I, IGFBP-3, and IGFBP-7 Levels in Relation to Endocrine Treatment and Breast Cancer Recurrence: A Nested Case-Control Study
por: Rosendahl, Ann H., et al.
Publicado: (2021)

Impact of combining vitamin C with radiation therapy in human breast cancer: does it matter?
por: Khazaei, Somayeh, et al.
Publicado: (2022)

Androgen receptor expression and breast cancer mortality in a population-based prospective cohort
por: Elebro, Karin, et al.
Publicado: (2017)

Hormonal factors and pancreatic cancer risk in women: The Malmö Diet and Cancer Study
por: Andersson, Gustav, et al.
Publicado: (2018)

Statin-induced anti-proliferative effects via cyclin D1 and p27 in a window-of-opportunity breast cancer trial
por: Feldt, Maria, et al.
Publicado: (2015)

Pancreatic cancer risk in relation to sex, lifestyle factors, and pre-diagnostic anthropometry in the Malmö Diet and Cancer Study
por: Andersson, Gustav, et al.
Publicado: (2016)

Statin use and breast cancer survival – a Swedish nationwide study
por: Borgquist, Signe, et al.
Publicado: (2019)

Androgen receptor genotypes predict response to endocrine treatment in breast cancer patients
por: Lundin, K B, et al.
Publicado: (2011)

Effects of statin use on volumetric mammographic density: results from the KARMA study
por: Skarping, Ida, et al.
Publicado: (2015)

Statin use, HMGCR expression, and breast cancer survival – The Malmö Diet and Cancer Study
por: Bjarnadottir, Olöf, et al.
Publicado: (2020)

Prognostic impact of tumour-specific HMG-CoA reductase expression in primary breast cancer
por: Borgquist, Signe, et al.
Publicado: (2008)

Influence of anthropometric factors on tumour biological characteristics of colorectal cancer in men and women: a cohort study
por: Brändstedt, Jenny, et al.
Publicado: (2013)

The prognostic role of HER2 expression in ductal breast carcinoma in situ (DCIS); a population-based cohort study
por: Borgquist, Signe, et al.
Publicado: (2015)

High expression of cholesterol biosynthesis genes is associated with resistance to statin treatment and inferior survival in breast cancer
por: Kimbung, Siker, et al.
Publicado: (2016)

Ki67 proliferation in core biopsies versus surgical samples - a model for neo-adjuvant breast cancer studies
por: Romero, Quinci, et al.
Publicado: (2011)

Diet and body constitution in relation to subgroups of breast cancer defined by tumour grade, proliferation and key cell cycle regulators
por: Borgquist, Signe, et al.
Publicado: (2007)

HMG-CoA reductase expression in primary colorectal cancer correlates with favourable clinicopathological characteristics and an improved clinical outcome
por: Bengtsson, Erik, et al.
Publicado: (2014)

ABCB1 haplotypes do not influence transport or efficacy of tyrosine kinase inhibitors in vitro
por: Skoglund, Karin, et al.
Publicado: (2013)

Absence of the common Insulin-like growth factor-1 19-repeat allele is associated with early age at breast cancer diagnosis in multiparous women
por: Bågeman, E, et al.
Publicado: (2007)

Statins: a role in breast cancer therapy?
por: Borgquist, S., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_b3keq2vs8nosrue1or6fisc6o2